Bismuth containing quadruple and concomitant therapy for 2 weeks are effective for the first-line Helicobacter pylori eradication: A prospective randomized trial

被引：0
|
作者：
Woo, H. [1 ]
Chung, J. [1 ]
Kim, S. [1 ]
Kim, J. [1 ]
Kwon, K. [1 ]
Kim, K. [1 ]
Kim, Y. [1 ]
Park, D. [1 ]
机构：
[1] Gachon Univ, Gil Med Ctr, Incheon, South Korea
来源：
HELICOBACTER | 2017年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P02.39
引用
收藏
页数：2
相关论文
共 50 条
  • [21] EFFICACY OF CONCOMITANT NONBITHMUTH-BASED QUADRUPLE THERAPY AS FIRST-LINE TREATMENT FOR ERADICATION OF HELICOBACTER PYLORI
    Moon, B.
    Lim, H.
    Lee, S.
    Han, K.
    Chung, J.
    Lee, Y.
    HELICOBACTER, 2011, 16 : 131 - 132
  • [22] Evaluation of first-line bismuth-containing 7-day concomitant quintuple therapy for Helicobacter pylori eradication
    Ye, Jian Fang
    Hong, Jun Bo
    Zhu, Yin
    Xie, Yong
    Shu, Xu
    Luo, Ling Yu
    Xie, Chuan
    Zhu, Zhen Hua
    Lu, Nong Hua
    JOURNAL OF DIGESTIVE DISEASES, 2017, 18 (12) : 704 - 708
  • [23] Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study
    De Francesco, Vincenzo
    Hassan, Cesare
    Ridola, Lorenzo
    Giorgio, Floriana
    Ierardi, Enzo
    Zullo, Angelo
    JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 63 : 748 - 752
  • [24] Efficacy and Safety of 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Helicobacter pylori Eradication in the Elderly
    Ma, Te-Ling
    Tai, Wei-Chen
    Loke, Song-Seng
    Yao, Chih-Chien
    Liang, Chih-Ming
    Chuah, Seng-Kee
    DRUGS & AGING, 2023, 40 (01) : 71 - 79
  • [25] Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study
    De Francesco, Vincenzo
    Pontone, Stefano
    Bellesia, Annamaria
    Serviddio, Gaetano
    Panetta, Cristina
    Palma, Rossella
    Zullo, Angelo
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : 139 - 141
  • [26] Comparison of Bismuth Containing Quadruple Therapy and Tailored Therapy for Helicobacter pylori Eradication According to Clarithromycin Resistance: A Prospective Randomized Controlled Trial
    Bang, Byoung Wook
    Ko, Eun Jung
    Kwon, Kye Sook
    Shin, Yong Woon
    Kim, Hyung Kil
    DIGESTION, 2020, 101 (01) : 97 - 97
  • [27] Efficacy and Safety of 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Helicobacter pylori Eradication in the Elderly
    Te-Ling Ma
    Wei-Chen Tai
    Song-Seng Loke
    Chih-Chien Yao
    Chih-Ming Liang
    Seng-Kee Chuah
    Drugs & Aging, 2023, 40 : 71 - 79
  • [28] Comparison of Bismuth containing quadruple therapy and tailored therapy for Helicobacter pylori eradication according to clarithromycin resistance; a prospective randomized controlled trial
    Kim, H.
    Bang, B.
    Ko, E.
    Shin, Y.
    HELICOBACTER, 2018, 23
  • [29] Triple therapy versus concomitant therapy for the first-line Helicobacter pylori eradication
    Lee, M.
    Kim, G.
    Lee, B.
    Jeon, H.
    Park, E.
    Song, G.
    HELICOBACTER, 2017, 22
  • [30] Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen
    Aksoy, Evrim Kahramanoglu
    Sapmaz, Ferdane Pirincci
    Goktas, Zeynep
    Uzman, Metin
    Nazligul, Yasar
    MEDICAL PRINCIPLES AND PRACTICE, 2017, 26 (06) : 523 - 529
12345